Disruptive technologies in interventional & surgical innovations are reshaping therapeutic possibilities in pulmonary care. From robotic-assisted thoracic surgery to endobronchial valves and navigational bronchoscopy, procedures once considered high-risk are becoming minimally invasive and more precise. These advances have expanded treatment options for emphysema, early-stage lung cancers, and airway obstructions. Innovations in lung volume reduction techniques and 3D-printed airway stents are enhancing both outcomes and recovery times. Interventional & Surgical Innovations not only enable better anatomical access but also reduce patient morbidity through image-guided planning and real-time intraoperative feedback. Increasingly, hybrid operating suites and simulation-based surgical training are equipping clinicians to deliver safer, faster, and more personalized care. Regulatory alignment and surgical data registries are also contributing to global benchmarking and continuous improvement in procedural standards.
Title : Changing population immunity to COVID-19 in the context of infection, vaccination and emerging SARS-CoV-2 variants
Ranjan Ramasamy, ID-FISH Technology, United States
Title : Non-canonical IRF3 functions in limiting pulmonary inflammation
Saurabh Chattopadhyay, University of Kentucky, United States
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : The representational challenge for designing and managing intelligent and ethical 5P medicine pulmonary, respiratory and lung health care systems
Habil Bernd Blobel, University of Regensburg, Germany
Title : From Chronic Obstructive Pulmonary Disease (COPD) to Non-Small Cell Lung Cancer (NSCLC): T helper cell epigenetic modifications and cancer risk
Koustav Sarkar, SRM Institute of Science and Technology, India
Title : Bacterial profile of community acquired pneumonia in a public health institute
Sayan Bhattacharyya, AIIH&PH, India